EUVIMEDEUVIMED entdecken
Crossref

The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation

Bo Pang, Lu-Lu Zhang, Bin Li, Feng-Xian Sun, Zhi-Da Wang

Physiology & Behavior · 2023

DOI: 10.1016/j.physbeh.2023.114134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiology & Behavior, 2023. Verfasst von Bo Pang und 4 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tia…. Hauptthemen laut MEDLINE: Alzheimer Disease, Sodium-Glucose Transporter 2 Inhibitors, Symporters. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseSodium-Glucose Transporter 2 InhibitorsSymportersRatsMaleAnimalsInsulinGlycogen Synthase Kinase 3 betatau ProteinsProto-Oncogene Proteins c-aktAcetylcholinesteraseRats, WistarBrainStreptozocinGlucoseSodiumDisease Models, AnimalBridged Bicyclo Compounds, Heterocyclic

Stichwörter der Autor:innen

Alzheimer's diseaseBrain insulin signalingCognitive impairmentErtugliflozinTau hyperphosphorylation

Substanzen

InsulinGlycogen Synthase Kinase 3 betatau ProteinsProto-Oncogene Proteins c-aktSodium-Glucose Transporter 2 InhibitorsAcetylcholinesteraseStreptozocinGlucoseSymportersSodium

Autor:innen und Institutionen

  • NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China; Tianjin Key Laboratory of Metabolic Diseases, Tian…
  • Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China.
  • Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Zitieren

APA

Pang, B., Zhang, L. L., Li, B., Sun, F. X., & Wang, Z. D. (2023). The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation. Physiology & Behavior. https://doi.org/10.1016/j.physbeh.2023.114134

Vancouver

Pang B, Zhang LL, Li B, Sun FX, Wang ZD. The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation. Physiology & Behavior. 2023. doi:10.1016/j.physbeh.2023.114134

BibTeX
@article{Pang2023,
  author = {Pang, Bo and Zhang, Lu-Lu and Li, Bin and Sun, Feng-Xian and Wang, Zhi-Da},
  title = {The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation},
  journal = {Physiology & Behavior},
  year = {2023},
  doi = {10.1016/j.physbeh.2023.114134}
}
Kostenlos starten →